Skip to content
CRR logo
Submit Search
Join E-mail List | Contact Us
  • Topics
  • Publications
  • Initiatives
  • Data
  • Sponsors
  • Opportunities
  • About Us
  • Search

How to Fix the Too-high 2022 Medicare Part B Premium?

July 7, 2022
Share
Mobile Share Email Facebook Bluesky Twitter LinkedIn

MarketWatch Blog by Alicia H. Munnell

Headshot of Alicia H. Munnell

Alicia H. Munnell is a columnist for MarketWatch and senior advisor of the Center for Retirement Research at Boston College.

Mid-year reductions and refunds don’t work; savings will be reflected in 2023 premium.

In November 2021, the Centers for Medicare and Medicaid Services (CMS) announced that the Medicare part B premium would increase by 14.5 percent.  Roughly half of this increase was attributable to the need to create a contingency reserve to cover significantly higher expenditures associated with Aduhelm, Biogen’s controversial new drug aimed at slowing the loss in cognition from Alzheimer’s disease.  The estimated cost for one year’s treatment was $56,000. 

Part B covers physician and outpatient hospital services and, relevant for this discussion, drugs that are administered in a physician’s office rather than purchased at a pharmacy. (Medicare Part D covers retail prescription drugs.) The Part B premium is set at 25% of projected program costs and must ensure that the program’s Trust Fund has sufficient reserves to cover costs during the year. 

After the Part B premium increase was determined, two things happened.  First, in December 2021 Biogen announced that it would cut the price of Aduhelm nearly in half to $28,200 annually.  Second, in January 2022 CMS issued a preliminary decision to limit Medicare’s coverage of the new drug to those enrolled in clinical trials, greatly restricting its use.  (This decision was finalized in April.) 

In January 2022, the Secretary of Health and Human Services asked CMS to reassess its recommendation for the Part B premium.  The agency considered three options: 1) making a mid-year change in the premium; 2) sending out refund checks; and 3) incorporating the savings into the 2023 premium.

Apparently, the Part B premium has never been redetermined; the statute says that the determination should be made for the entire year.  Moreover, in May 2022, CMS concluded that recalculating the premium would be very complicated, involve significant resources, and require a number of entities that are involved in the payment of the premium for different groups of beneficiaries to make major operational changes.

The idea of sending out refund checks was even less appealing.  CMS concluded that the agency only had the authority to send premium refund checks in instances of overpayment relative to the established premium.

Thus, the decision has been made to incorporate the savings into the 2023 premium, which will be determined in the fall.  How would that work?  The 2022 Part B premium is $170.10.  If all spending assumptions remained unchanged but the actual price of Aduhelm was reduced to $28,200 and the decision to limit coverage to clinical trials was incorporated, the premium would have been $160.40.  My sense is that the premium will not actually be reduced but rather held at $170.10 for 2023, as projected in the federal budget.  However, the excess assets in the Medicare Part B trust fund should further dampen premium growth after 2023.

The CMS approach seems quite sensible given the technical problems associated with mid-year corrections and refunds.  A year with no Part B premium increase will be a welcome respite and allow retirees to use their entire Social Security cost-of-living adjustment to cover rising prices for other goods and services.

Stethoscope and piggy bank on blue background
Stethoscope and piggy bank on blue background
Related Content

Read on MarketWatch

Topics
Social Security
Publication Type
MarketWatch Blog
Related Articles
stethoscope on banknote and piggy bank on white background

The Medicare Trustees Report Contained No Bad News. Now for the Bad Part.

MarketWatch Blog by Alicia H. Munnell

September 4, 2024
Stethoscope with money and calculator, closeup. Health care conc

Medicare Finances: A 2024 Update

Issue Brief by Alicia H. Munnell

July 30, 2024
Photo of a nursing home

Nursing Homes are Far Short of New Staff Requirements

Squared Away Blog by Kimberly Blanton

June 11, 2024

Support timely research that informs real-world solutions.

About us
Contact
Join e-mail list
Facebook Bluesky Twitter LinkedIn Instagram YouTube RSS

© 2025 Trustees of Boston College, Center for Retirement Research|Terms of Use|Privacy Policy|Accessibility

This website uses cookies to improve your experience. We also use IP addresses, domain information and other access statistics to administer the site and analyze usage trends. If you prefer to opt out, you can select Update settings. Read our Privacy Policy. Accept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT